LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Center
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CDMO
      • Quality System
      • CDMO Service
      • Quality Control
      • Global CDMO
      • CDMO Inquiries
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • CDMO Inquiries
    • IR Inquiries

Quantity of Cord Blood under Custody Exceeds 200,000 Units for the First Time in Korea

2015/01/27
CORD BLOOD BANK

MEDIPOST achieved 200,000 units of cord blood under custody for the first time in Korea.

This number is similar to the level under custody by major advanced countries such as U.S. Europe and Japan etc., accounting for 40% of whole domestic cord blood units under custody.

MEDIPOST started cord blood custody service opening Celltree cord blood bank in December 2000, and achieved this grand record in 14 years.

MEDIPOST is keeping the number one market share by widest margin among 17 domestic cord blood banks, in custody of over 15,000 units for recent 3 consecutive years.

MEDIPOST obtained modern facilities such as automatic nitrogen recharge system under central control and internally developed portable cord blood custody tank etc., at its own building located at Pangyo Techno Valley. And remarkably enhanced confidence and stability of cord blood custody.

VIEW LIST

Related News

news 200518
Star Actress Choi Jiwoo Stores Her Baby’s Umbilical Cord Blo…
2020/05/18
news 180108
Longer-Term Storage of Cord Blood Gains Popularity Over 20,0…
2020/04/29

Latest News

news 1
MEDIPOST Recruits Local Experts to U.S. Subsidiary, Accelera…
2024/12/06
cartistem package
MEDIPOST Completes Administration for Phase 3 Clinical Trial…
2024/11/22
news 241022
MEDIPOST Affiliate OmniaBio Hosts Opening Ceremony for New C…
2024/10/21
news 241015
MEDIPOST Discusses CARTISTEM® Partnerships and Licensing Opp…
2024/10/14
news 1
MEDIPOST Recruits Local Experts to U.S. Subsidiary, Accelera…
2024/12/06
cartistem package
MEDIPOST Completes Administration for Phase 3 Clinical Trial…
2024/11/22
news 241022
MEDIPOST Affiliate OmniaBio Hosts Opening Ceremony for New C…
2024/10/21
news 241015
MEDIPOST Discusses CARTISTEM® Partnerships and Licensing Opp…
2024/10/14

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

Latest News

MEDIPOST Recruits Local Experts to U.S.…2024.12.06
MEDIPOST Completes Administration for Ph…2024.11.22
MEDIPOST Affiliate OmniaBio Hosts Openin…2024.10.21
MEDIPOST Discusses CARTISTEM® Partnershi…2024.10.14
MEDIPOST’s CARTISTEM® Reaches Milestone…2024.06.24

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST